Fungal Infections in Patients with Walled-off Pancreatic Necrosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Fungal Infections in Patients with Walled-off Pancreatic Necrosis. / Werge, Mikkel; Roug, Stine; Novovic, Srdan; Schmidt, Palle Nordblad; Hansen, Erik Feldager; Knudsen, Jenny Dahl.

I: Pancreas, Bind 45, Nr. 10, 2016, s. 1447-1451.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Werge, M, Roug, S, Novovic, S, Schmidt, PN, Hansen, EF & Knudsen, JD 2016, 'Fungal Infections in Patients with Walled-off Pancreatic Necrosis', Pancreas, bind 45, nr. 10, s. 1447-1451. https://doi.org/10.1097/MPA.0000000000000675

APA

Werge, M., Roug, S., Novovic, S., Schmidt, P. N., Hansen, E. F., & Knudsen, J. D. (2016). Fungal Infections in Patients with Walled-off Pancreatic Necrosis. Pancreas, 45(10), 1447-1451. https://doi.org/10.1097/MPA.0000000000000675

Vancouver

Werge M, Roug S, Novovic S, Schmidt PN, Hansen EF, Knudsen JD. Fungal Infections in Patients with Walled-off Pancreatic Necrosis. Pancreas. 2016;45(10):1447-1451. https://doi.org/10.1097/MPA.0000000000000675

Author

Werge, Mikkel ; Roug, Stine ; Novovic, Srdan ; Schmidt, Palle Nordblad ; Hansen, Erik Feldager ; Knudsen, Jenny Dahl. / Fungal Infections in Patients with Walled-off Pancreatic Necrosis. I: Pancreas. 2016 ; Bind 45, Nr. 10. s. 1447-1451.

Bibtex

@article{903597f769d04329a7f47f4ed0876c83,
title = "Fungal Infections in Patients with Walled-off Pancreatic Necrosis",
abstract = "Objectives This study aimed to evaluate the influence of fungal infection and antifungal treatment on outcome in patients with walled-off pancreatic necrosis (WON). Methods A retrospective description of fungal infections in a cohort of consecutive patients undergoing endoscopic, transmural drainage and necrosectomy for WON, treated in a tertiary referral center was reviewed. Results Between 2005 and 2013, fungal infection in WON was documented in 57 (46%) of 123 patients. The most common isolates at first positive culture were Candida albicans (55%) and Candida glabrata (20%). Thirty-nine (70%) patients were treated with antifungals after the first fungal finding. There was no significant difference in mortality (21% vs 13%, P = 0.517) or organ failure (34% vs 33%, P = 0.903) between the group treated with adequate antifungals after the first fungal finding compared to the group not treated or treated inadequately. The in-hospital mortality was 18% (10 patients). Concomitant fungemia was found in 6 patients, of which 3 died, as opposed to 7 with fungi in the necrosis only (50% vs 14%, P = 0.027). Conclusions This study demonstrates a high incidence and associated high in-hospital mortality of fungal infection in WON, thus emphasizing the importance of fungal infections in WON.",
keywords = "antifungal treatment, candida, mortality, necrotizing pancreatitis",
author = "Mikkel Werge and Stine Roug and Srdan Novovic and Schmidt, {Palle Nordblad} and Hansen, {Erik Feldager} and Knudsen, {Jenny Dahl}",
year = "2016",
doi = "10.1097/MPA.0000000000000675",
language = "English",
volume = "45",
pages = "1447--1451",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams & Wilkins",
number = "10",

}

RIS

TY - JOUR

T1 - Fungal Infections in Patients with Walled-off Pancreatic Necrosis

AU - Werge, Mikkel

AU - Roug, Stine

AU - Novovic, Srdan

AU - Schmidt, Palle Nordblad

AU - Hansen, Erik Feldager

AU - Knudsen, Jenny Dahl

PY - 2016

Y1 - 2016

N2 - Objectives This study aimed to evaluate the influence of fungal infection and antifungal treatment on outcome in patients with walled-off pancreatic necrosis (WON). Methods A retrospective description of fungal infections in a cohort of consecutive patients undergoing endoscopic, transmural drainage and necrosectomy for WON, treated in a tertiary referral center was reviewed. Results Between 2005 and 2013, fungal infection in WON was documented in 57 (46%) of 123 patients. The most common isolates at first positive culture were Candida albicans (55%) and Candida glabrata (20%). Thirty-nine (70%) patients were treated with antifungals after the first fungal finding. There was no significant difference in mortality (21% vs 13%, P = 0.517) or organ failure (34% vs 33%, P = 0.903) between the group treated with adequate antifungals after the first fungal finding compared to the group not treated or treated inadequately. The in-hospital mortality was 18% (10 patients). Concomitant fungemia was found in 6 patients, of which 3 died, as opposed to 7 with fungi in the necrosis only (50% vs 14%, P = 0.027). Conclusions This study demonstrates a high incidence and associated high in-hospital mortality of fungal infection in WON, thus emphasizing the importance of fungal infections in WON.

AB - Objectives This study aimed to evaluate the influence of fungal infection and antifungal treatment on outcome in patients with walled-off pancreatic necrosis (WON). Methods A retrospective description of fungal infections in a cohort of consecutive patients undergoing endoscopic, transmural drainage and necrosectomy for WON, treated in a tertiary referral center was reviewed. Results Between 2005 and 2013, fungal infection in WON was documented in 57 (46%) of 123 patients. The most common isolates at first positive culture were Candida albicans (55%) and Candida glabrata (20%). Thirty-nine (70%) patients were treated with antifungals after the first fungal finding. There was no significant difference in mortality (21% vs 13%, P = 0.517) or organ failure (34% vs 33%, P = 0.903) between the group treated with adequate antifungals after the first fungal finding compared to the group not treated or treated inadequately. The in-hospital mortality was 18% (10 patients). Concomitant fungemia was found in 6 patients, of which 3 died, as opposed to 7 with fungi in the necrosis only (50% vs 14%, P = 0.027). Conclusions This study demonstrates a high incidence and associated high in-hospital mortality of fungal infection in WON, thus emphasizing the importance of fungal infections in WON.

KW - antifungal treatment

KW - candida

KW - mortality

KW - necrotizing pancreatitis

U2 - 10.1097/MPA.0000000000000675

DO - 10.1097/MPA.0000000000000675

M3 - Journal article

C2 - 27518465

AN - SCOPUS:84981736908

VL - 45

SP - 1447

EP - 1451

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 10

ER -

ID: 179089320